[1] KONG P,CHRISTIA P,FRANGOGIANNIS N G.The pathogenesis of cardiac fibrosis[J].Cell Mol Life Sci,2014,71(4):549-574.
[2] BRILLA C G.Regression of myocardial fibrosis in hypertensive heart disease:diverse effects of various antihypertensive drugs[J].Cardiovasc Res,2000,46(2):324-331.
[3] BRILLA C G,FUNCK R C,RUPP H.Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease[J].Circulation,2000,102(12):1388-1393.
[4] LOPEZ B,QUEREJETA R,VARO N,et al.Usefulness of serum carboxy-terminal propeptide of procollagen type Ⅰ in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients[J].Circulation,2001,104(3):286-291.
[5] SHI Q,ABUSARAH J,BAROUDI G,et al.Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis[J].Arthritis Res Ther,2012,14(5):R223.
[6] AKASHIBA A,ONO H,ONO Y,et al.Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ss inhibition and apoptosis induction in spontaneously hypertensive rats[J].J Cardiol,2008,52(3):239-246.
[7] SUKUMARAN V,WATANABE K,VEERAVEEDU P T,et al.Telmisartan,an angiotensin-Ⅱ receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy[J].Hypertens Res,2010,33(7):695-702.
[8] SHIMADA Y J,PASSERI J J,BAGGISH A L,et al.Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy[J].JACC Heart Fail,2013,1(6):480-487.
[9] WENG L Q,ZHANG W B,YE Y,et al.Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice[J].Acta Pharmacol Sin,2014,35(8):1005-1014.
[10] WONG K Y,WONG S Y,MCSWIGGAN S,et al.Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors:a randomised placebo-controlled cross-over trial[J].Int J Cardiol,2013,168(6):5229-5233.
[11] 孙涛,沈潞华,陈晖,等.β受体阻滞剂对心力衰竭大鼠模型心肌纤维化的影响[J].中华心血管病杂志,2008,36(1):68-71.
[12] AROZAL W,SARI F R,WATANABE K,et al.Carvedilol-afforded protection against daunorubicin-induced cardiomyopathic rats in vivo:effects on cardiac fibrosis and hypertrophy[J].ISRN Pharmacol,2011,2011:430549.
[13] SEVILLA M A,VOCES F,CARRON R,et al.Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats:persistent effects after withdrawal[J].Life Sci,2004,75(7):881-891.
[14] BUSSEUIL D,SHI Y,MECTEAU M,et al.Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis[J].Cardiology,2010,117(3):234-242.
[15] LI Y C,LUO Q,GE L S,et al.Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis[J].Biochem Biophys Res Commun,2013,431(3):450-455.
[16] 曹蕾,刘乃丰.他汀类药物干预心肌纤维化的机制[J].东南大学学报:医学版,2012,31(4):496-500.
[17] MA Y X,LI W H,XIE Q.Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats[J].Pharmazie,2013,68(5):355-358.
[18] ABE Y,IZUMI T,URABE A,et al.Pravastatin prevents myocardium from ischemia-induced fibrosis by protecting vascular endothelial cells exposed to oxidative stress[J].Cardiovasc Drugs Ther,2006,20(4):273-280.
[19] AKAHORI H,TSUJINO T,NAITO Y,et al.Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats[J].J Hypertens,2014,32(7):1534-1541.
[20] OGATA T,MIYAUCHI T,SAKAI S,et al.Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate,partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway[J].J Am Coll Cardiol,2004,43(8):1481-1488.
[21] ZHANG W,CHANCEY A L,TZENG H P,et al.The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions[J].Circulation,2011,124(19):2106-2116.
[22] DUERRSCHMID C,CRAWFORD J R,REINEKE E,et al.TNF receptor 1 signaling is critically involved in mediating angiotensin-Ⅱ-induced cardiac fibrosis[J].J Mol Cell Cardiol,2013,57:59-67.
[23] HONSHO S,NISHIKAWA S,AMANO K,et al.Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways[J].Circ Res,2009,105(11):1149-1158.
[24] SZARDIEN S,NEF H M,VOSS S,et al.Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1beta synthesis[J].Eur Heart J,2012,33(5):595-605.
[25] QIAO W,WANG C,CHEN B,et al.Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats[J].Cardiology,2015,131(2):97-106.
[26] ZHANG Z,QU X,NI Y,et al.Triptolide protects rat heart against pressure overload-induced cardiac fibrosis[J].Int J Cardiol,2013,168(3):2498-2505.
[27] NAGAYAMA T,HSU S,ZHANG M,et al.Sildenafil stops progressive chamber,cellular,and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload[J].J Am Coll Cardiol,2009,53(2):207-215.
[28] CHEN J,SHEARER G C,CHEN Q,et al.Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts[J].Circulation,2011,123(6):584-593.
[29] LIU X,GAI Y,LIU F,et al.Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway[J].Cardiovasc Res,2010,88(1):150-158.
[30] INTHACHAI T,LEKAWANVIJIT S,KUMFU S,et al.Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction[J].Exp Physiol,2015,100(6):667-679.
[31] XIAO H,MA X,FENG W,et al.Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway[J].Cardiovasc Res,2010,87(3):504-513.
[32] LEE J E,YI C O,JEON B T,et al.Alpha-lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats[J].Cardiovasc Diabetol,2012,11:111.
[33] WANG Z F,WANG N P,HARMOUCHE S,et al.Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats[J].Basic Res Cardiol,2013,108(1):318.
[34] ELNAKISH M T,KUPPUSAMY P,KHAN M.Stem cell transplantation as a therapy for cardiac fibrosis[J].J Pathol,2013,229(2):347-354.
[35] GIELING R G,BURT A D,MANN D A.Fibrosis and cirrhosis reversibility-molecular mechanisms[J].Clin Liver Dis,2008,12(4):915-937.
[36] YAMAGAMI K,OKA T,WANG Q,et al.Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts[J].Am J Physiol Heart Circ Physiol,2015,309(3):H512-522.
[37] 孙孟华,李秀,刘巍.组蛋白脱乙酰化酶抑制剂抗心脏纤维化作用及免疫机制[J].国际免疫学杂志,2015,38(4):371-374. |
